JP7228896B2 - 乳がん患者の予後の予測方法 - Google Patents

乳がん患者の予後の予測方法 Download PDF

Info

Publication number
JP7228896B2
JP7228896B2 JP2019527493A JP2019527493A JP7228896B2 JP 7228896 B2 JP7228896 B2 JP 7228896B2 JP 2019527493 A JP2019527493 A JP 2019527493A JP 2019527493 A JP2019527493 A JP 2019527493A JP 7228896 B2 JP7228896 B2 JP 7228896B2
Authority
JP
Japan
Prior art keywords
breast cancer
prognosis
genes
predicting
gene
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
JP2019527493A
Other languages
English (en)
Japanese (ja)
Other versions
JP2020500515A (ja
JP2020500515A5 (https=
Inventor
レ チョ、サン
ホ ムン、ユン
イル ハン、チン
キ シン、ヨン
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Gencurix Inc
Original Assignee
Gencurix Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Gencurix Inc filed Critical Gencurix Inc
Publication of JP2020500515A publication Critical patent/JP2020500515A/ja
Publication of JP2020500515A5 publication Critical patent/JP2020500515A5/ja
Application granted granted Critical
Publication of JP7228896B2 publication Critical patent/JP7228896B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Images

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
    • C12Q1/6886—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material for cancer
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/118—Prognosis of disease development
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/158—Expression markers

Landscapes

  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Engineering & Computer Science (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Immunology (AREA)
  • Analytical Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • Pathology (AREA)
  • Physics & Mathematics (AREA)
  • Biotechnology (AREA)
  • Microbiology (AREA)
  • Molecular Biology (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Hospice & Palliative Care (AREA)
  • Oncology (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
JP2019527493A 2016-11-25 2017-11-27 乳がん患者の予後の予測方法 Active JP7228896B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
KR1020160158466A KR101896545B1 (ko) 2016-11-25 2016-11-25 유방암 환자의 예후 예측 방법
KR10-2016-0158466 2016-11-25
PCT/KR2017/013602 WO2018097678A1 (ko) 2016-11-25 2017-11-27 유방암 환자의 예후 예측 방법

Publications (3)

Publication Number Publication Date
JP2020500515A JP2020500515A (ja) 2020-01-16
JP2020500515A5 JP2020500515A5 (https=) 2021-01-14
JP7228896B2 true JP7228896B2 (ja) 2023-02-27

Family

ID=62195317

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2019527493A Active JP7228896B2 (ja) 2016-11-25 2017-11-27 乳がん患者の予後の予測方法

Country Status (7)

Country Link
US (1) US11220716B2 (https=)
EP (1) EP3524689B1 (https=)
JP (1) JP7228896B2 (https=)
KR (1) KR101896545B1 (https=)
CN (2) CN110023513A (https=)
ES (1) ES2962775T3 (https=)
WO (1) WO2018097678A1 (https=)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR101950717B1 (ko) * 2016-11-23 2019-02-21 주식회사 젠큐릭스 유방암 환자의 화학치료 유용성 예측 방법
EP3856933A1 (en) * 2018-09-27 2021-08-04 BioNTech Diagnostics GmbH Predictive and prognostic methods in breast cancer
US12019674B2 (en) 2019-05-29 2024-06-25 New York University System and method for tumor characterization
CN110938698A (zh) * 2019-12-27 2020-03-31 南京医科大学 Sox9在预测三阴性乳腺癌对CDK7抑制剂THZ1敏感性中的应用
EP3907301A1 (en) * 2020-05-08 2021-11-10 Istituto Europeo di Oncologia S.r.l. Methods and kits for determining the risk of breast cancer recurrence
KR102422610B1 (ko) * 2020-05-12 2022-07-18 서울대학교 산학협력단 초기 유방암 환자의 예후 예측 방법
CN113355419B (zh) * 2021-06-28 2022-02-18 广州中医药大学(广州中医药研究院) 一种乳腺癌预后风险预测标志组合物及应用
KR102789795B1 (ko) * 2021-09-23 2025-04-01 사회복지법인 삼성생명공익재단 유방 재건술 예후를 예측하기 위한 정보의 제공 방법 및 시스템
CN113981081A (zh) * 2021-10-22 2022-01-28 中山大学 一种基于rna编辑水平的乳腺癌分子标志物及诊断模型
CN113862363A (zh) * 2021-10-27 2021-12-31 中山大学附属第一医院 免疫相关基因在乳腺癌预后的试剂盒和系统中的应用
KR102778416B1 (ko) 2022-02-07 2025-03-07 사회복지법인 삼성생명공익재단 유방 재건술 예후를 예측하기 위한 정보의 제공 방법 및 시스템
KR102849648B1 (ko) 2022-02-07 2025-08-21 사회복지법인 삼성생명공익재단 유방 재건술 예후를 예측하기 위한 정보의 제공 방법 및 시스템
KR20230119541A (ko) 2022-02-07 2023-08-16 사회복지법인 삼성생명공익재단 유방 재건술 예후를 예측하기 위한 정보의 제공 방법 및 시스템
KR20230119540A (ko) 2022-02-07 2023-08-16 사회복지법인 삼성생명공익재단 유방 재건술의 예후를 예측하기 위한 정보의 제공 방법 및 시스템
WO2025110726A1 (ko) * 2023-11-20 2025-05-30 주식회사 디시젠 콕스 회귀 분석 알고리즘을 적용한 암 위험도에 대한 정보를 제공하는 방법
CN117589991B (zh) * 2024-01-18 2024-03-29 天津云检医学检验所有限公司 一种用于乳腺癌患者her2表达状态鉴定的生物标志物、模型、试剂盒及用途

Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2011526487A (ja) 2008-07-02 2011-10-13 セントロ・デ・インベステイガイシオネス・エネルゲテイカス，メデイオアムビエンタレス・イ・テクノロヒカス・（セ．イ．エ．エメ．ア．テ．） 乳癌のゲノムフィンガープリント
JP2013523105A (ja) 2010-03-31 2013-06-17 ジヴィドン ダイアグノスティックス ゲゼルシャフト ミット ベシュレンクテル ハフツング 内分泌治療下における乳癌再発を予測するための方法
JP2016516426A (ja) 2013-04-18 2016-06-09 ジェンキュリクス インクＧｅｎｃｕｒｉｘ Ｉｎｃ． 早期乳癌の予後予測診断用遺伝子マーカーおよびその用途

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR101287600B1 (ko) * 2011-01-04 2013-07-18 주식회사 젠큐릭스 초기유방암의 예후 예측용 유전자 및 이를 이용한 초기유방암의 예후예측 방법
KR101725985B1 (ko) * 2013-01-28 2017-04-13 주식회사 젠큐릭스 초기유방암의 예후 예측용 유전자 및 이를 이용한 초기유방암의 예후예측 방법
US10655187B2 (en) * 2013-04-18 2020-05-19 Gencurix Inc. Genetic marker for early breast cancer prognosis prediction and diagnosis, and use thereof
KR101748867B1 (ko) * 2013-04-19 2017-06-20 주식회사 젠큐릭스 조기 유방암 예후 예측 진단용 자동화 시스템

Patent Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2011526487A (ja) 2008-07-02 2011-10-13 セントロ・デ・インベステイガイシオネス・エネルゲテイカス，メデイオアムビエンタレス・イ・テクノロヒカス・（セ．イ．エ．エメ．ア．テ．） 乳癌のゲノムフィンガープリント
JP2013523105A (ja) 2010-03-31 2013-06-17 ジヴィドン ダイアグノスティックス ゲゼルシャフト ミット ベシュレンクテル ハフツング 内分泌治療下における乳癌再発を予測するための方法
JP2016516426A (ja) 2013-04-18 2016-06-09 ジェンキュリクス インクＧｅｎｃｕｒｉｘ Ｉｎｃ． 早期乳癌の予後予測診断用遺伝子マーカーおよびその用途

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
武田薬品工業株式会社, "乳がんの病期分類（ＴＮＭ分類）｜今すぐ知りたい！乳がん", [online], 2016.03.24, [令和３年９月２４日検索], <URL: http://takeda.co.jp/patients/disease/b_cancer/what/wh_05.html>

Also Published As

Publication number Publication date
EP3524689C0 (en) 2023-09-06
JP2020500515A (ja) 2020-01-16
EP3524689B1 (en) 2023-09-06
EP3524689A1 (en) 2019-08-14
WO2018097678A1 (ko) 2018-05-31
EP3524689A4 (en) 2020-05-27
KR20180059192A (ko) 2018-06-04
ES2962775T3 (es) 2024-03-21
CN110023513A (zh) 2019-07-16
US11220716B2 (en) 2022-01-11
CN116356030A (zh) 2023-06-30
US20180216199A1 (en) 2018-08-02
KR101896545B1 (ko) 2018-09-07

Similar Documents

Publication Publication Date Title
JP7228896B2 (ja) 乳がん患者の予後の予測方法
JP7042784B2 (ja) 遺伝子発現を用いた前立腺癌の予後を定量化する方法
JP7430415B2 (ja) 乳がん患者の化学治療の有用性を予測する方法
CN105339797B (zh) 早期乳腺癌的预后预测诊断用基因标记物及其用途
JP2019527544A (ja) 分子マーカー、参照遺伝子、及びその応用、検出キット、並びに検出モデルの構築方法
MX2013013746A (es) Biomarcadores para cancer de pulmon.
CN101960022A (zh) Ⅱ期和ⅲ期结肠癌的分子分期和预后
CN103384829A (zh) 预测大肠直肠癌复发的生物标记
US11840733B2 (en) Method for predicting prognosis of breast cancer patient
WO2023152568A2 (en) Compositions and methods for characterizing lung cancer
US11845993B2 (en) Methods for identifying prostate cancer
KR101504818B1 (ko) 위암에 대한 예후 예측 시스템

Legal Events

Date Code Title Description
A80 Written request to apply exceptions to lack of novelty of invention

Free format text: JAPANESE INTERMEDIATE CODE: A80

Effective date: 20190729

Free format text: JAPANESE INTERMEDIATE CODE: A801

Effective date: 20190729

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20201125

A621 Written request for application examination

Free format text: JAPANESE INTERMEDIATE CODE: A621

Effective date: 20201125

A977 Report on retrieval

Free format text: JAPANESE INTERMEDIATE CODE: A971007

Effective date: 20210929

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20211005

A601 Written request for extension of time

Free format text: JAPANESE INTERMEDIATE CODE: A601

Effective date: 20211224

A601 Written request for extension of time

Free format text: JAPANESE INTERMEDIATE CODE: A601

Effective date: 20220304

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20220405

A02 Decision of refusal

Free format text: JAPANESE INTERMEDIATE CODE: A02

Effective date: 20220712

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20221110

C60 Trial request (containing other claim documents, opposition documents)

Free format text: JAPANESE INTERMEDIATE CODE: C60

Effective date: 20221110

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A821

Effective date: 20221111

A911 Transfer to examiner for re-examination before appeal (zenchi)

Free format text: JAPANESE INTERMEDIATE CODE: A911

Effective date: 20221201

C21 Notice of transfer of a case for reconsideration by examiners before appeal proceedings

Free format text: JAPANESE INTERMEDIATE CODE: C21

Effective date: 20221206

TRDD Decision of grant or rejection written
A01 Written decision to grant a patent or to grant a registration (utility model)

Free format text: JAPANESE INTERMEDIATE CODE: A01

Effective date: 20230110

A61 First payment of annual fees (during grant procedure)

Free format text: JAPANESE INTERMEDIATE CODE: A61

Effective date: 20230207

R150 Certificate of patent or registration of utility model

Ref document number: 7228896

Country of ref document: JP

Free format text: JAPANESE INTERMEDIATE CODE: R150

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250